Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen et al.
CELL (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
Isabella Quinti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1 beta-mediated colitis
Liming Mao et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
Annarosa Soresina et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
Estefania Mira et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Mark Roschewski et al.
SCIENCE IMMUNOLOGY (2020)
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson et al.
NATURE (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement
Filomena Monica Cavaliere et al.
PLOS ONE (2017)
Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
Jingxian Zhao et al.
SCIENCE IMMUNOLOGY (2017)
Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy
David Bearden et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)
Tyrosine Kinase Btk Is Required for NK Cell Activation
Yan Bao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
Kuan-Hsiang G. Huang et al.
NATURE COMMUNICATIONS (2010)
Impaired Antibody Response Causes Persistence of Prototypic T Cell-Contained Virus
Andreas Bergthaler et al.
PLOS BIOLOGY (2009)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease
Gerond Lake-Bakaar et al.
BLOOD (2007)
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals
LQ Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence
P Seiler et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
